Nelipak Corporation, a leading global provider of healthcare packaging solutions, announced the opening of its new Asia-Pacific Technical Development Centre located in Singapore. This helps to establish an integrated technical development capability in the Asia-Pacific region, combining Nelipak’s flexible and rigid sterile barrier packaging design and innovation capabilities under one roof.
Vice President and General Manager, Asia, Aldin Velic explain Pharmaceutical and medical device companies can adopt a holistic sterile barrier system design instead of fragmented components, accelerating the product development process and launch.
The U.S. sterilized packaging market is projected to experience significant growth, with estimates suggesting the market size will increase from USD 35.83 billion in 2026 to approximately USD 71.63 billion by 2035, representing a compound annual growth rate (CAGR) of 8% from 2026 to 2035. Growth is driven by growing consumer awareness regarding food safety and quality, with rising demand for Sterilised Packaging Solutions, this led to contributing to the market's expansion.
This investment marks a major milestone in Nelipak’s global growth strategy and establishes a permanent technical and innovation presence in one of the world’s fastest-growing medical device innovation and manufacturing hubs. Singapore offers a launchpad to Asia-Pacific’s medtech and biomedical industries, owing to the country’s strong global connectivity and growing healthcare manufacturing and research capabilities.
Real-time collaboration with Nelipak’s global manufacturing and innovation network ensures packaging solutions developed in Asia-Pacific are globally scalable and production-ready.
Vice President and General Manager, Asia-Pacific, Nelipak, Aldin Velic said Our goal with this centre is simple. Customers walk in with a device and a packaging challenge, and they leave with an engineered packaging solution, prototype samples in hand, and a clear path to development, validation, and commercialisation. We are replacing distance, delay, and fragmentation with expertise, speed, and collaboration.
A recent report by Towards Packaging highlights that the U.S. sterilized packaging market is witnessing an increasing prevalence of chronic diseases, an aging population, and a surge in medical device and pharmaceutical manufacturing. Innovation in materials and technologies is emerging, allowing for more effective sterilisation processes and enhanced shelf life. Regulatory standards are evolving, compelling manufacturers to adopt advanced packaging solutions that comply with stringent safety requirements.
North America is the largest market for sterilised packaging, primarily due to its established healthcare infrastructure and the high prevalence of advanced medical procedures. The Asia Pacific region is emerging as the fastest-growing market, fueled by increasing healthcare investments and a rising population.
30 April 2026
30 April 2026
30 April 2026
30 April 2026